BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 29128791)

  • 1. ACPA and JWH-133 modulate the vascular tone of superior mesenteric arteries through cannabinoid receptors, BK
    López-Dyck E; Andrade-Urzúa F; Elizalde A; Ferrer-Villada T; Dagnino-Acosta A; Huerta M; Osuna-Calleros Z; Rangel-Sandoval C; Sánchez-Pastor E
    Pharmacol Rep; 2017 Dec; 69(6):1131-1139. PubMed ID: 29128791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid receptor type 1 activation by arachidonylcyclopropylamide in rat aortic rings causes vasorelaxation involving calcium-activated potassium channel subunit alpha-1 and calcium channel, voltage-dependent, L type, alpha 1C subunit.
    Sánchez-Pastor E; Andrade F; Sánchez-Pastor JM; Elizalde A; Huerta M; Virgen-Ortiz A; Trujillo X; Rodríguez-Hernández A
    Eur J Pharmacol; 2014 Apr; 729():100-6. PubMed ID: 24561046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
    Járai Z; Wagner JA; Varga K; Lake KD; Compton DR; Martin BR; Zimmer AM; Bonner TI; Buckley NE; Mezey E; Razdan RK; Zimmer A; Kunos G
    Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14136-41. PubMed ID: 10570211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries.
    Stanley CP; Hind WH; Tufarelli C; O'Sullivan SE
    Pharmacol Res; 2016 Nov; 113(Pt A):356-363. PubMed ID: 27633407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Ca2+-dependent potassium channels in in vitro anandamide-mediated mesenteric vasorelaxation in rats with biliary cirrhosis.
    Yang YY; Lin HC; Huang YT; Lee TY; Hou MC; Wang YW; Lee FY; Lee SD
    Liver Int; 2007 Oct; 27(8):1045-55. PubMed ID: 17845532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 pathway contributes to methanandamide-induced vasorelaxation in rat aorta.
    López-Miranda V; Dannert MT; Herradón E; Alsasua A; Martín MI
    Cardiovasc Drugs Ther; 2010 Dec; 24(5-6):379-89. PubMed ID: 20814734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Curcumin-Induced Vasorelaxation in Rat Superior Mesenteric Arteries.
    Zhang H; Liu H; Chen Y; Zhang Y
    Ann Vasc Surg; 2018 Apr; 48():233-240. PubMed ID: 28943490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced endothelium-dependent relaxation to anandamide in mesenteric arteries from young obese Zucker rats.
    Lobato NS; Filgueira FP; Prakash R; Giachini FR; Ergul A; Carvalho MH; Webb RC; Tostes RC; Fortes ZB
    PLoS One; 2013; 8(5):e63449. PubMed ID: 23667622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric artery.
    Ho WS; Hiley CR
    J Pharm Pharmacol; 2004 Jul; 56(7):869-75. PubMed ID: 15233865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apelin Reduces Nitric Oxide-Induced Relaxation of Cerebral Arteries by Inhibiting Activation of Large-Conductance, Calcium-Activated K Channels.
    Mughal A; Sun C; OʼRourke ST
    J Cardiovasc Pharmacol; 2018 Apr; 71(4):223-232. PubMed ID: 29620606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms involved in oleamide-induced vasorelaxation in rat mesenteric resistance arteries.
    Sudhahar V; Shaw S; Imig JD
    Eur J Pharmacol; 2009 Apr; 607(1-3):143-50. PubMed ID: 19326479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries.
    O'Sullivan SE; Kendall DA; Randall MD
    Br J Pharmacol; 2004 Jun; 142(3):435-42. PubMed ID: 15148250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large conductance Ca2+-activated K+ channels modulate endothelial cell outward currents and nitric oxide release in the intact rat superior mesenteric artery.
    Climent B; Schubert R; Stankevicius E; García-Sacristán A; Simonsen U; Rivera L
    Biochem Biophys Res Commun; 2012 Jan; 417(3):1007-13. PubMed ID: 22209788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular pharmacology of a novel cannabinoid-like compound, 3-(5-dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1-methyl-ethyl)benzamide (VSN16) in the rat.
    Hoi PM; Visintin C; Okuyama M; Gardiner SM; Kaup SS; Bennett T; Baker D; Selwood DL; Hiley CR
    Br J Pharmacol; 2007 Nov; 152(5):751-64. PubMed ID: 17891160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid agonists induce relaxation in the bovine ophthalmic artery: evidences for CB1 receptors, nitric oxide and potassium channels.
    Romano MR; Lograno MD
    Br J Pharmacol; 2006 Apr; 147(8):917-25. PubMed ID: 16474412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation.
    Stanley CP; Hind WH; Tufarelli C; O'Sullivan SE
    Cardiovasc Res; 2015 Sep; 107(4):568-78. PubMed ID: 26092099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Ca
    Garcia DCG; Lopes MJ; Mbiakop UC; Lemos VS; Cortes SF
    Life Sci; 2019 Aug; 231():116555. PubMed ID: 31194991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capsaicin Causes Vasorelaxation of Rat Aorta through Blocking of L-type Ca
    Andrade F; Rangel-Sandoval C; Rodríguez-Hernández A; López-Dyck E; Elizalde A; Virgen-Ortiz A; Bonales-Alatorre E; Valencia-Cruz G; Sánchez-Pastor E
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32872656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
    Ramírez BG; Blázquez C; Gómez del Pulgar T; Guzmán M; de Ceballos ML
    J Neurosci; 2005 Feb; 25(8):1904-13. PubMed ID: 15728830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Underlying mechanisms preserving coronary basal tone and NO-mediated relaxation in obesity: Involvement of β1 subunit-mediated upregulation of BK
    Climent B; Sánchez A; Moreno L; Pérez-Vizcaíno F; García-Sacristán A; Rivera L; Prieto D
    Atherosclerosis; 2017 Aug; 263():227-236. PubMed ID: 28672269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.